| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-06-3473 |
| P698 | PubMed publication ID | 17332351 |
| P50 | author | Paul Workman | Q7154482 |
| Chrisostomos Prodromou | Q28317140 | ||
| Richard Marais | Q30118915 | ||
| Florence Raynaud | Q62089079 | ||
| Wynne Aherne | Q114109796 | ||
| Kwai-Ming J. Cheung | Q114109804 | ||
| Kathy Boxall | Q114109811 | ||
| Laurence Pearl | Q6500833 | ||
| P2093 | author name string | Angela Hayes | |
| Edward McDonald | |||
| Gary Box | |||
| Alison Maloney | |||
| Martin Rowlands | |||
| Lisa Patterson | |||
| Sharon Sanderson | |||
| Karen Ball | |||
| Sue Eccles | |||
| Marissa Powers | |||
| Paul A. Clarke | |||
| S. Mark Roe | |||
| Swee Y. Sharp | |||
| Thomas P. Matthews | |||
| P2860 | cites work | Mutations of the BRAF gene in human cancer | Q27860760 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cct-018159 | Q27096815 |
| cancer research | Q3421914 | ||
| P304 | page(s) | 2206-2216 | |
| P577 | publication date | 2007-03-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | In vitro Biological Characterization of a Novel, Synthetic Diaryl Pyrazole Resorcinol Class of Heat Shock Protein 90 Inhibitors | |
| P478 | volume | 67 |
| Q51549127 | A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma. |
| Q47121587 | A cassaine diterpene alkaloid, 3β-acetyl-nor-erythrophlamide, suppresses VEGF-induced angiogenesis and tumor growth via inhibiting eNOS activation |
| Q39666425 | A cell-based screen for inhibitors of protein folding and degradation |
| Q48343445 | A small-molecule screen reveals that HSP90β promotes the conversion of induced pluripotent stem cell-derived endoderm to a hepatic fate and regulates HNF4A turnover |
| Q37120694 | Acquired resistance to 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) in glioblastoma cells |
| Q24655984 | Antimelanoma activity of the redox dye DCPIP (2,6-dichlorophenolindophenol) is antagonized by NQO1 |
| Q27673253 | Co-Crystalization and In Vitro Biological Characterization of 5-Aryl-4-(5-Substituted-2-4-Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors |
| Q38841186 | Design and synthesis of pyrazole/isoxazole linked arylcinnamides as tubulin polymerization inhibitors and potential antiproliferative agents |
| Q55646587 | Development of a screening strategy for new modulators of T cell receptor signaling and T cell activation. |
| Q27654646 | Different Poses for Ligand and Chaperone in Inhibitor-Bound Hsp90 and GRP94: Implications for Paralog-Specific Drug Design |
| Q34278997 | Effects of HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) on NEU/HER2 overexpressing mammary tumours in MMTV-NEU-NT mice monitored by Magnetic Resonance Spectroscopy |
| Q35517613 | Heat shock protein-90 inhibitors enhance antigen expression on melanomas and increase T cell recognition of tumor cells |
| Q37891987 | Heat-shock protein 90 inhibitors as antitumor agents: a survey of the literature from 2005 to 2010. |
| Q91949588 | Hsp90β interacts with MDM2 to suppress p53-dependent senescence during skeletal muscle regeneration |
| Q90176619 | Identification of Anti-Mycobacterium and Anti-Legionella Compounds With Potential Distinctive Structural Scaffolds From an HD-PBL Using Phenotypic Screens in Amoebae Host Models |
| Q33571026 | Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel |
| Q36741693 | Inhibition of gastric tumor growth by a novel Hsp90 inhibitor |
| Q38950783 | Inhibition of heat shock protein 90 decreases ACTH production and cell proliferation in AtT-20 cells |
| Q36845355 | Inhibitors of the heat shock response: biology and pharmacology |
| Q41904818 | Measurement of nanomolar dissociation constants by titration calorimetry and thermal shift assay - radicicol binding to Hsp90 and ethoxzolamide binding to CAII |
| Q42770281 | Mode of cell death induced by the HSP90 inhibitor 17-AAG (tanespimycin) is dependent on the expression of pro-apoptotic BAX. |
| Q34249948 | Modulation of melanoma cell phospholipid metabolism in response to heat shock protein 90 inhibition |
| Q33565686 | N-benzyl-5-phenyl-1H-pyrazole-3-carboxamide promotes vascular endothelial cell angiogenesis and migration in the absence of serum and FGF-2 |
| Q38502737 | Natural Product Inspired N-Terminal Hsp90 Inhibitors: From Bench to Bedside? |
| Q37215989 | New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential. |
| Q34001269 | Probing the probes: fitness factors for small molecule tools |
| Q36661483 | Proteome alteration induced by hTERT transfection of human fibroblast cells |
| Q39982294 | Signalling profile and antitumour activity of the novel Hsp90 inhibitor NVP-AUY922 in multiple myeloma. |
| Q48542611 | Structural ensemble-based docking simulation and biophysical studies discovered new inhibitors of Hsp90 N-terminal domain |
| Q45409941 | Studies on synthetic and structural characterization of new fluorine substituted phthalides of pharmaceutical interest |
| Q35837669 | Synthesis, characterization, and pharmacological evaluation of novel azolo- and azinothiazinones containing 2,4-dihydroxyphenyl substituent as anticancer agents |
| Q28314990 | Targeting the ATP-dependent formation of herpesvirus ribonucleoprotein particle assembly as an antiviral approach |
| Q36804122 | The hemopexin domain of MMP3 is responsible for mammary epithelial invasion and morphogenesis through extracellular interaction with HSP90β |
| Q34288879 | Thermodynamics of aryl-dihydroxyphenyl-thiadiazole binding to human Hsp90 |
Search more.